Curation OPDM1 LRP12
12 + 0 = 12 / 18
Genetic evidence
Total: 12
Category | Type | Citation | Score | Details |
|---|---|---|---|---|
Singular Evidence | Probands | 6 | Study screened 17 familial and 17 sporadic OPDM probands with rimmed vacuoles after excluding PABPN1 and LOC642361/NUTM2B-AS1 expansions; LRP12 5′ UTR CGG expansions were confirmed by RP-PCR in 13/34 probands (5 familial, 8 sporadic). An additional 9/54 clinically similar probands without available biopsy also carried LRP12 expansions. | |
Collective Evidence | Allele | 1 | In 60 OPDM_LRP12 patients, LRP12 CGG expansions ranged from 85 to 289 repeats; among 52 non-mosaic patients, repeat size showed a negative correlation with age at onset (r² = 0.188, P = .001). | |
Collective Evidence | Computational | 0.5 | TRhist analysis of whole-genome sequencing identified a CGG expansion at chr8:104,588,973–104,588,999 in the LRP12 5′ UTR. Fragment analysis showed 13–45 repeat units in 998/1,000 controls, while 2/1,000 controls had expansions confirmed by RP-PCR and Southern blot. | |
Statistics | Case-control data | 6 | Among 198 unrelated Japanese families/208 patients with suspected OPDM or OPMD after PABPN1 exclusion, LRP12 expansions were identified in 42 families with rimmed vacuoles and 17 families without biopsy; no LRP12 expansion was detected in 47 families without rimmed vacuoles. |
Experimental evidence
Total: 0
No experimental evidence details available.